Ron Finklestien
Noteworthy Tuesday Option Activity: HIMS, CPRI, X
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Hims & Hers Health Inc (Symbol: HIMS), ...
Marriott’s (MAR) Ritz-Carlton Reserve Debuts in the Middle East
Marriott International, Inc.’s MAR luxury brand, Ritz-Carlton, announced the debut of Ritz-Carlton Reserve property in the Middle East under the name of Nujuma. Located ...
Cameco closes $366 million debt offering
“Consistent with the conservative financial management we have demonstrated, our capital allocation decisions are focused on maintaining the financial flexibility to execute on our ...
Investors Heavily Search The Trade Desk (TTD): Here is What You Need to Know
The Trade Desk (TTD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of ...
Investors Heavily Search Celsius Holdings Inc. (CELH): Here is What You Need to Know
Celsius Holdings Inc. (CELH) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of ...
Invest in These 5 Small-Cap Stocks Despite Inflation Headwind
Wall Street has been witnessing an impressive bull run since the beginning of 2023 barring last month. Year to date, — the three major ...
1 Unstoppable Growth Stock Trading at a Price You May Never See Again
All it takes is one incredible growth stock to supercharge your portfolio. If you find that high-growth stock, it can make up for other ...
J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate
Johnson & Johnson JNJ announced a definitive agreement with Swiss biotech Numab Therapeutics to acquire global rights to NM26, a phase II-ready bispecific antibody ...
